Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Clinical Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of BMX-010 Ointment in Adult Subjects With Atopic Dermatitis

NCT05491447 is registered in ClinicalTrials.gov with BioMimetix JV, LLC as lead sponsor.

NCT NCT05491447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05491447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Clinical Trial to Evaluate the Safety, Clinical Effects, and Systemic Exposure of a Topical Application of BMX-010 Ointment in Adult Subjects With Atopic Dermatitis
Lead sponsor
BioMimetix JV, LLC
Phase
Phase 2
Overall status
Terminated
Start date
January 8, 2023
Completion date
April 15, 2024
Enrollment
103 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis